Concepts (207)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Urinary Tract | 9 | 2022 | 287 | 1.800 |
Why?
|
| Urogenital Abnormalities | 7 | 2022 | 240 | 1.640 |
Why?
|
| Nephrosis | 1 | 2021 | 50 | 0.830 |
Why?
|
| Nephrotic Syndrome | 6 | 2021 | 392 | 0.810 |
Why?
|
| Hernia, Hiatal | 1 | 2021 | 80 | 0.790 |
Why?
|
| Microcephaly | 1 | 2021 | 392 | 0.630 |
Why?
|
| Autonomic Nervous System Diseases | 1 | 2019 | 260 | 0.620 |
Why?
|
| Receptors, Nicotinic | 1 | 2019 | 485 | 0.600 |
Why?
|
| Mutation, Missense | 3 | 2021 | 2503 | 0.530 |
Why?
|
| Vesico-Ureteral Reflux | 5 | 2022 | 417 | 0.520 |
Why?
|
| Kidney | 12 | 2022 | 6888 | 0.490 |
Why?
|
| Renal Insufficiency, Chronic | 3 | 2019 | 1938 | 0.430 |
Why?
|
| Podocytes | 5 | 2021 | 409 | 0.420 |
Why?
|
| Pedigree | 7 | 2020 | 4724 | 0.340 |
Why?
|
| Mutation | 10 | 2021 | 29262 | 0.330 |
Why?
|
| DNA-Binding Proteins | 4 | 2021 | 9774 | 0.320 |
Why?
|
| Transcription Factors | 5 | 2021 | 12005 | 0.280 |
Why?
|
| Heart Diseases | 2 | 2021 | 2759 | 0.270 |
Why?
|
| Congenital Abnormalities | 2 | 2020 | 696 | 0.270 |
Why?
|
| Ventricular Remodeling | 1 | 2012 | 1280 | 0.260 |
Why?
|
| Kidney Transplantation | 1 | 2019 | 4116 | 0.250 |
Why?
|
| Intranuclear Space | 1 | 2021 | 16 | 0.210 |
Why?
|
| Amino Acid Substitution | 3 | 2021 | 1823 | 0.210 |
Why?
|
| Spinal Dysraphism | 1 | 2022 | 147 | 0.200 |
Why?
|
| Tracheoesophageal Fistula | 1 | 2021 | 109 | 0.200 |
Why?
|
| Kidney Diseases | 2 | 2021 | 2124 | 0.190 |
Why?
|
| Myocardium | 2 | 2012 | 4969 | 0.190 |
Why?
|
| Esophageal Atresia | 1 | 2021 | 172 | 0.180 |
Why?
|
| Protein Stability | 1 | 2021 | 569 | 0.180 |
Why?
|
| Repressor Proteins | 2 | 2021 | 3075 | 0.180 |
Why?
|
| Collagen Type IV | 1 | 2019 | 143 | 0.180 |
Why?
|
| Gene Knockdown Techniques | 2 | 2021 | 1728 | 0.180 |
Why?
|
| rho GTP-Binding Proteins | 1 | 2020 | 302 | 0.180 |
Why?
|
| Zinc Fingers | 1 | 2021 | 599 | 0.180 |
Why?
|
| Fraser Syndrome | 1 | 2018 | 5 | 0.170 |
Why?
|
| Eye Abnormalities | 1 | 2020 | 219 | 0.170 |
Why?
|
| Genetic Predisposition to Disease | 5 | 2021 | 17218 | 0.170 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2021 | 3026 | 0.160 |
Why?
|
| Gene Knockout Techniques | 1 | 2021 | 819 | 0.160 |
Why?
|
| Glomerulosclerosis, Focal Segmental | 1 | 2021 | 335 | 0.160 |
Why?
|
| Xenopus laevis | 1 | 2021 | 1012 | 0.150 |
Why?
|
| Rhabdomyolysis | 1 | 2017 | 151 | 0.150 |
Why?
|
| Exercise | 1 | 2012 | 5251 | 0.150 |
Why?
|
| Forkhead Transcription Factors | 2 | 2020 | 1600 | 0.150 |
Why?
|
| Actins | 2 | 2021 | 2191 | 0.150 |
Why?
|
| Genetic Testing | 2 | 2019 | 3303 | 0.140 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2021 | 707 | 0.140 |
Why?
|
| Microfilament Proteins | 1 | 2020 | 1210 | 0.130 |
Why?
|
| Xenopus | 3 | 2020 | 767 | 0.130 |
Why?
|
| Tretinoin | 1 | 2017 | 527 | 0.130 |
Why?
|
| Drug Resistance | 1 | 2019 | 1611 | 0.120 |
Why?
|
| Models, Molecular | 2 | 2021 | 5525 | 0.120 |
Why?
|
| Membrane Proteins | 2 | 2020 | 8072 | 0.110 |
Why?
|
| Developmental Disabilities | 1 | 2021 | 1370 | 0.110 |
Why?
|
| Child, Preschool | 5 | 2021 | 41081 | 0.110 |
Why?
|
| Gene Expression Regulation, Developmental | 2 | 2021 | 3813 | 0.110 |
Why?
|
| Cell Line | 3 | 2021 | 16657 | 0.110 |
Why?
|
| Amino Acid Sequence | 2 | 2021 | 14215 | 0.100 |
Why?
|
| Transposition of Great Vessels | 1 | 2015 | 560 | 0.100 |
Why?
|
| CCAAT-Enhancer-Binding Protein-beta | 1 | 2010 | 102 | 0.100 |
Why?
|
| Ventricular Function, Right | 1 | 2015 | 580 | 0.100 |
Why?
|
| Echocardiography, Doppler | 1 | 2015 | 972 | 0.100 |
Why?
|
| Prognosis | 3 | 2019 | 28919 | 0.100 |
Why?
|
| Phenotype | 4 | 2021 | 16306 | 0.090 |
Why?
|
| Glucocorticoids | 1 | 2019 | 2125 | 0.090 |
Why?
|
| Hospitals, Pediatric | 1 | 2019 | 1776 | 0.090 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2020 | 2895 | 0.090 |
Why?
|
| Exercise Tolerance | 1 | 2015 | 802 | 0.090 |
Why?
|
| Heterozygote | 3 | 2020 | 2780 | 0.090 |
Why?
|
| Glycolates | 1 | 2008 | 38 | 0.090 |
Why?
|
| Arabs | 2 | 2021 | 130 | 0.090 |
Why?
|
| Magnetic Resonance Imaging, Cine | 1 | 2015 | 935 | 0.090 |
Why?
|
| Graft Survival | 1 | 2019 | 3767 | 0.080 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2021 | 3708 | 0.080 |
Why?
|
| Child | 9 | 2021 | 73636 | 0.080 |
Why?
|
| Nerve Tissue Proteins | 1 | 2021 | 4592 | 0.080 |
Why?
|
| Humans | 25 | 2022 | 708843 | 0.080 |
Why?
|
| Physical Conditioning, Animal | 1 | 2010 | 377 | 0.080 |
Why?
|
| Epigenesis, Genetic | 1 | 2020 | 3464 | 0.080 |
Why?
|
| Exercise Test | 1 | 2015 | 2125 | 0.080 |
Why?
|
| Carrier Proteins | 1 | 2021 | 5141 | 0.080 |
Why?
|
| Animals | 13 | 2022 | 170486 | 0.080 |
Why?
|
| Consanguinity | 2 | 2019 | 465 | 0.080 |
Why?
|
| Epilepsy | 1 | 2021 | 2892 | 0.070 |
Why?
|
| Male | 13 | 2022 | 349524 | 0.070 |
Why?
|
| Female | 13 | 2022 | 375205 | 0.070 |
Why?
|
| Boston | 1 | 2019 | 9402 | 0.070 |
Why?
|
| Survival Analysis | 1 | 2019 | 10507 | 0.070 |
Why?
|
| Graft Rejection | 1 | 2019 | 4408 | 0.070 |
Why?
|
| Genetic Variation | 1 | 2020 | 6666 | 0.070 |
Why?
|
| Alleles | 3 | 2021 | 7090 | 0.070 |
Why?
|
| Infant, Newborn | 2 | 2022 | 24433 | 0.070 |
Why?
|
| Mice | 10 | 2022 | 80876 | 0.070 |
Why?
|
| Homozygote | 2 | 2019 | 1849 | 0.060 |
Why?
|
| Hepatocyte Nuclear Factor 3-gamma | 1 | 2022 | 9 | 0.060 |
Why?
|
| Hepatocyte Nuclear Factor 3-beta | 1 | 2022 | 70 | 0.060 |
Why?
|
| Cohort Studies | 3 | 2020 | 39292 | 0.060 |
Why?
|
| Infant | 2 | 2021 | 34261 | 0.060 |
Why?
|
| Hemizygote | 1 | 2021 | 30 | 0.060 |
Why?
|
| Polyethylene Glycols | 1 | 2008 | 1198 | 0.060 |
Why?
|
| Age of Onset | 2 | 2019 | 3330 | 0.060 |
Why?
|
| Nuclear Proteins | 1 | 2017 | 5982 | 0.050 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2021 | 15485 | 0.050 |
Why?
|
| Amphibian Proteins | 1 | 2020 | 37 | 0.050 |
Why?
|
| Genes, X-Linked | 1 | 2021 | 133 | 0.050 |
Why?
|
| Adolescent | 5 | 2022 | 84718 | 0.050 |
Why?
|
| Follow-Up Studies | 2 | 2019 | 39038 | 0.050 |
Why?
|
| Genetic Association Studies | 2 | 2021 | 2709 | 0.050 |
Why?
|
| Severity of Illness Index | 1 | 2019 | 16008 | 0.050 |
Why?
|
| Receptors, Interleukin | 1 | 2021 | 247 | 0.050 |
Why?
|
| Risk Assessment | 2 | 2019 | 23284 | 0.050 |
Why?
|
| Pseudopodia | 1 | 2020 | 197 | 0.050 |
Why?
|
| DNA Mutational Analysis | 2 | 2019 | 4317 | 0.050 |
Why?
|
| Glomerular Basement Membrane | 1 | 2019 | 28 | 0.050 |
Why?
|
| Codon, Nonsense | 1 | 2021 | 288 | 0.050 |
Why?
|
| Ireland | 1 | 2019 | 155 | 0.050 |
Why?
|
| Larva | 1 | 2020 | 513 | 0.040 |
Why?
|
| Prostate-Specific Antigen | 1 | 2008 | 2245 | 0.040 |
Why?
|
| HSP90 Heat-Shock Proteins | 1 | 2021 | 470 | 0.040 |
Why?
|
| Kidney Diseases, Cystic | 1 | 2019 | 180 | 0.040 |
Why?
|
| Young Adult | 3 | 2019 | 55940 | 0.040 |
Why?
|
| Urogenital System | 1 | 2018 | 83 | 0.040 |
Why?
|
| Kidney Glomerulus | 1 | 2020 | 703 | 0.040 |
Why?
|
| Heart | 1 | 2010 | 4315 | 0.040 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2019 | 756 | 0.040 |
Why?
|
| Signal Transduction | 2 | 2020 | 23950 | 0.040 |
Why?
|
| Gender Identity | 1 | 2022 | 554 | 0.040 |
Why?
|
| Creatinine | 1 | 2022 | 1885 | 0.040 |
Why?
|
| Cytoplasm | 1 | 2020 | 1634 | 0.040 |
Why?
|
| Jews | 1 | 2017 | 365 | 0.040 |
Why?
|
| Nanoparticles | 1 | 2008 | 2048 | 0.040 |
Why?
|
| Hedgehog Proteins | 1 | 2020 | 774 | 0.040 |
Why?
|
| Animals, Genetically Modified | 1 | 2020 | 1589 | 0.030 |
Why?
|
| Cytoskeletal Proteins | 1 | 2021 | 1421 | 0.030 |
Why?
|
| Mice, Knockout | 2 | 2021 | 15274 | 0.030 |
Why?
|
| Medical History Taking | 1 | 2019 | 804 | 0.030 |
Why?
|
| Treatment Outcome | 2 | 2019 | 61932 | 0.030 |
Why?
|
| Adult | 5 | 2021 | 211041 | 0.030 |
Why?
|
| Estradiol | 1 | 2022 | 1974 | 0.030 |
Why?
|
| Conserved Sequence | 1 | 2018 | 1246 | 0.030 |
Why?
|
| Glomerular Filtration Rate | 1 | 2022 | 2090 | 0.030 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2018 | 851 | 0.030 |
Why?
|
| Retrospective Studies | 2 | 2019 | 71483 | 0.030 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2018 | 2926 | 0.030 |
Why?
|
| Sex Distribution | 1 | 2018 | 2328 | 0.030 |
Why?
|
| Fetus | 1 | 2020 | 1828 | 0.030 |
Why?
|
| Calcium-Binding Proteins | 1 | 2018 | 1101 | 0.030 |
Why?
|
| Gene Frequency | 1 | 2019 | 3701 | 0.030 |
Why?
|
| Animals, Newborn | 1 | 2018 | 2877 | 0.030 |
Why?
|
| Databases, Genetic | 1 | 2019 | 1807 | 0.030 |
Why?
|
| Disease Models, Animal | 2 | 2022 | 18375 | 0.030 |
Why?
|
| Exons | 1 | 2018 | 2472 | 0.030 |
Why?
|
| Homeodomain Proteins | 1 | 2021 | 2459 | 0.030 |
Why?
|
| HEK293 Cells | 1 | 2021 | 4310 | 0.030 |
Why?
|
| Testosterone | 1 | 2022 | 2352 | 0.030 |
Why?
|
| RNA, Small Interfering | 1 | 2020 | 3645 | 0.030 |
Why?
|
| Models, Animal | 1 | 2018 | 2221 | 0.030 |
Why?
|
| Area Under Curve | 1 | 2015 | 1688 | 0.020 |
Why?
|
| Evolution, Molecular | 1 | 2019 | 1959 | 0.020 |
Why?
|
| Single-Cell Analysis | 1 | 2021 | 2159 | 0.020 |
Why?
|
| Rats | 2 | 2021 | 25094 | 0.020 |
Why?
|
| Family | 1 | 2020 | 3087 | 0.020 |
Why?
|
| Genetic Loci | 1 | 2019 | 2587 | 0.020 |
Why?
|
| Piperidones | 1 | 2008 | 17 | 0.020 |
Why?
|
| Chemistry, Physical | 1 | 2008 | 162 | 0.020 |
Why?
|
| Observer Variation | 1 | 2015 | 2687 | 0.020 |
Why?
|
| Benzeneacetamides | 1 | 2008 | 42 | 0.020 |
Why?
|
| Chemical Phenomena | 1 | 2008 | 563 | 0.020 |
Why?
|
| Cell Movement | 1 | 2020 | 5489 | 0.020 |
Why?
|
| Protein Binding | 1 | 2020 | 9639 | 0.020 |
Why?
|
| Biophysical Phenomena | 1 | 2008 | 333 | 0.020 |
Why?
|
| Embryo, Nonmammalian | 1 | 2010 | 957 | 0.020 |
Why?
|
| ROC Curve | 1 | 2015 | 3518 | 0.020 |
Why?
|
| Biophysics | 1 | 2008 | 394 | 0.020 |
Why?
|
| Computational Biology | 1 | 2019 | 3568 | 0.020 |
Why?
|
| Polyglycolic Acid | 1 | 2008 | 431 | 0.020 |
Why?
|
| Risk Factors | 1 | 2012 | 69553 | 0.020 |
Why?
|
| Surface Properties | 1 | 2008 | 1209 | 0.020 |
Why?
|
| Genomics | 1 | 2019 | 5300 | 0.020 |
Why?
|
| Endocytosis | 1 | 2008 | 1018 | 0.010 |
Why?
|
| Molecular Structure | 1 | 2008 | 1971 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2018 | 14836 | 0.010 |
Why?
|
| Lactic Acid | 1 | 2008 | 1126 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2020 | 21194 | 0.010 |
Why?
|
| Disease Progression | 1 | 2019 | 13298 | 0.010 |
Why?
|
| Myocytes, Cardiac | 1 | 2010 | 1641 | 0.010 |
Why?
|
| Mice, Nude | 1 | 2008 | 3859 | 0.010 |
Why?
|
| Ligands | 1 | 2008 | 3297 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2015 | 12447 | 0.010 |
Why?
|
| Incidence | 1 | 2018 | 20320 | 0.010 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2008 | 3714 | 0.010 |
Why?
|
| Zebrafish | 1 | 2010 | 3038 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2015 | 15252 | 0.010 |
Why?
|
| Mice, Inbred BALB C | 1 | 2008 | 6684 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2022 | 50597 | 0.010 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2008 | 3700 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2015 | 19423 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2010 | 10803 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2010 | 20170 | 0.010 |
Why?
|
| Brain | 1 | 2020 | 24969 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2019 | 58184 | 0.010 |
Why?
|
| Time Factors | 1 | 2015 | 41038 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2010 | 22989 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2010 | 12447 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2008 | 16959 | 0.010 |
Why?
|
| Aged | 1 | 2019 | 161488 | 0.000 |
Why?
|
| Middle Aged | 1 | 2019 | 213752 | 0.000 |
Why?
|
Concepts
(207)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(44)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_